THURMAN RANDY H bought OTLK

May 26, 2026 · Form 4 insider transaction

THURMAN RANDY H bought 5,000 shares of Outlook Therapeutics, Inc. at $0.43 per share, a transaction worth $2.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.